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Abstract
Background: The use of Cardiovascular Disease (CVD) risk estimation scores in primary prevention has long been
established. However, their performance still remains a matter of concern. The aim of this study was to explore the
potential of using ML methodologies on CVD prediction, especially compared to established risk tool, the HellenicSCORE.
Methods: Data from the ATTICA prospective study (n = 2020 adults), enrolled during 2001–02 and followed-up in 2011–
12 were used. Three different machine-learning classifiers (k-NN, random forest, and decision tree) were trained
and evaluated against 10-year CVD incidence, in comparison with the HellenicSCORE tool (a calibration of the ESC
SCORE). Training datasets, consisting from 16 variables to only 5 variables, were chosen, with or without bootstrapping,
in an attempt to achieve the best overall performance for the machine learning classifiers.
Results: Depending on the classifier and the training dataset the outcome varied in efficiency but was comparable
between the two methodological approaches. In particular, the HellenicSCORE showed accuracy 85%, specificity 20%,
sensitivity 97%, positive predictive value 87%, and negative predictive value 58%, whereas for the machine learning
methodologies, accuracy ranged from 65 to 84%, specificity from 46 to 56%, sensitivity from 67 to 89%, positive
predictive value from 89 to 91%, and negative predictive value from 24 to 45%; random forest gave the best
results, while the k-NN gave the poorest results.
Conclusions: The alternative approach of machine learning classification produced results comparable to that of
risk prediction scores and, thus, it can be used as a method of CVD prediction, taking into consideration the advantages
that machine learning methodologies may offer.
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Background
Developed and developing countries have succeeded in
protecting their populations from infectious and para-
sitic diseases through structured health systems and
preventive campaigns including vaccination policies
and regular health examinations [1, 2]. Interestingly,
while communicable diseases’ incidences have steeply
decreased during the past century, non-communicable
diseases, such as cardiovascular disease (CVD) and
malignancies have been both the direct and the under-
lying cause for the majority of deaths [3]. Although
CVD mortality rates are currently declining in most
European countries [4], there is an increasing non-fatal
CVD incidence, especially among females and younger
individuals, leading also to an increasing financial and
social cost [5, 6]. However, CVD is a highly avertable
health condition that can be prevented, delayed or even
well controlled when it is diagnosed at early stages of
atherosclerosis process, through a number of lifestyle
changes and accurate pharmaceutical treatment and
management. Under this context, an emerging need to
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better and early identify high-risk individuals is highlighted
as a first priority in order to reduce the burden of CVD,
allowing more effective intervention and thus more
disease-free years [7].
The use of CVD risk estimation scores (or tools) was
initially suggested in the Framingham study [8], which
was used to predict individual CVD risk in US, but also
in many other countries around the world, using low-
cost variables, such as age, gender, smoking habit, chol-
esterol and blood pressure levels, etc. [8]. In the early
2000s Menotti et al., [9] revealed some methodological
drawbacks of the Framingham CVD risk score when
applied to different populations around the world,
using the Seven Countries Study dataset. Similar con-
siderations have also arisen from various groups regard-
ing the accuracy of a health risk prediction tool when
applied to different population from the one that was de-
veloped. Under this context, in early 2000s, the European
Society of Cardiology (ESC) established the SCORE pro-
ject as an attempt to develop a more accurate risk predic-
tion tool for the European populations [10]. Since then,
the SCORE is being used across European countries whilst
many of these countries are using population-specific cali-
brated models in order to achieve the best individuals risk
predictions. Among them, one of the pioneer countries
was Greece which has recalibrated the European Society
of Cardiology (ESC) SCORE into the HellenicSCORE by
considering the prevalence of CVD risk factors in the
Greek population [11]. It should be noted here - for the
reader who is not familiar with CVD risk prediction scores
- that there is a variety of CVD risk prediction tools, from
different countries and populations, with different set of
risk factors used and with a large variation regarding their
performance. The majority of these scores use a common
set of the “classical” CVD risk factors, e.g., age, sex, smok-
ing, blood pressure and lipids levels, whereas others have
also incorporated more advanced markers of CVD disease.
The methodological framework of the vast majority of
these risk prediction tools is based on stochastic - statis-
tical - models that incorporate individual variables, based
on cohort studies, in order to calculate overall risk for a
future event [12]. Despite the aforementioned approaches
to early identify the potential CVD candidate through risk
prediction tools, a high percent of CVD events occurs in
people without established risk factors, or with low-to-
moderate overall risk, whereas, approximately 20% of
high-risk individuals, remain underestimated due to risk
misclassification, suggesting the need to identify new
methodologies that could optimize the performance of
risk prediction [13–16].
Due to the large amount of available data that requires
analytical processing, a category of algorithms for data
manipulation that has been introduced in various scien-
tific fields, including health, is that of machine learning
(ML). ML is a sub-area of artificial intelligence, with an
ultimate goal to devise learning algorithms that do the
learning automatically from the available data with min-
imal or even none human intervention. This area com-
prises numerous different types of algorithms capable of
processing large amounts of data and that ultimately
transform data into knowledge, which can be used to
infer some intelligent action or decision. The interest in
ML in health sciences has grown since the early 2000s
[17] and ML has been applied in various healthcare and
biomedicine applications [18], including cancer progno-
sis and prediction [19], radiologic imaging [20], the
understanding of ageing process [21] and of course CVD
risk prediction [22]. ML, similarly to well-known and
established statistical approaches, aims at “learning”
from data. In the statistical approach, mainly a probabilis-
tic model is built, based on the assumption that the pro-
vided data are a subset of a larger population that can be
described by a model. In principal, a simpler model is
much more preferable than a complex one, as long as
there is an acceptable performance. Moreover, human
intervention is considered essential in every stage of the
overall build of the model [23]. On the other hand, ML
emphasizes more on predictions and thus the efficiency is
evaluated via prediction performance.
The CVD risk estimation is clearly a typical classifica-
tion problem, where an individual must be somehow
categorized as having a low or a high CVD risk. As it
will be shown in the following, it is possible to correctly
classify an individual to an actual CVD risk class, using
ML techniques based on various easily accessible data
regarding individual’s bio-clinical risk factors, socio-eco-
nomic, lifestyle and psychological characteristics. Estab-
lished risk prediction tools, such as the HellenicSCORE,
induct their prediction based on a very limited number
of CVD risk factors that can be easily evaluated in daily
practice. On the contrary, ML techniques exploit the
majority of the available data, building much more com-
plex models considering many more features than only
the typical CVD risk factors. In the order to go forward
with the comparisons, among the vast variety of available
ML algorithms, three well-known and established ML al-
gorithms were chosen: a) One of the simplest classifiers,
the k-nearest neighbors’ algorithm (k-NN) [24], which is
yet quite efficient in general, b) A more complex one, the
Quinlan’s C5.0 decision tree algorithm [25] which uses a
tree structure to locate the connections among the data,
making the decision process quite transparent and in-
formative, and c) A quite complex meta-learning algo-
rithm, that of random forest (RF) [26].
Thus, the aim of the present work was to explore the
potential of using ML methodologies on total cardiomet-
abolic risk assessment of healthy adults. Therefore, the
predictive accuracy of ML methodologies was compared
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to already known and established risk prediction tools,
the HellenicSCORE, a calibration of the ESC SCORE,
against the 10-year combined (fatal or non-fatal) CVD
incidence; the research hypothesis was to evaluate which
approach for risk classification improves the correct
class CVD prediction rate of the referent population.
Figure 1 illustrates the methodological framework of the
present study, in a high-level approach.
Methods
The ATTICA study cohort
The working dataset was based on the ATTICA prospect-
ive cohort study, performed in the Athens metropolitan
area, Greece. During 2001–2002, n = 3042 Greek adults
(1528 women and 1514 men), stratified by age-sex cat-
egory of the Greek population (according to 2001 census),
were enrolled on a volunteer basis [27]. A large amount of
information was collected, and participants were followed
up in 2011–12 [28, 29]. Out of the 2583 individuals that
participated in the 10-year follow-up, n = 2020 partici-
pants had data without any missing information regarding
the development of a combined (fatal or nonfatal) CVD
event (coronary heart disease, angina, heart failure or
stroke, according to ICD-9 classification). The combined
10-year CVD incidence was 15.7% (19.7% in men and
11.7% in women, p for gender difference < 0.001). Table 1
illustrates baseline characteristics of the n = 2020 partici-
pants that were used as a sample for the development of
ML models.
The initial ATTICA study dataset underwent an intense
preprocessing phase before being used by the ML classi-
fiers. In a first step, from the dataset of 100 bio-clinical
and lifestyle behavior variables that have long been associ-
ated with the development of CVD, 43 were selected on
the bases of non-highly inter-correlated. This step was of
crucial importance, since the existence of numerous vari-
ables in a dataset may render the model very complex and
most probably over-fitted to the dataset. In the next step,
all variables with missing values in more than 70% of the
individuals were excluded. For some of the remaining 22
variables, there were some levels of missing data (< 10% of
the total sample), which were replaced by imputed data,
using the common approach of KNN imputation [30]
based on 10 neighbors. Moreover, a student’s t-test was
applied to compare each variable separately with the indi-
vidual’s classification as low or high CVD risk; variables
passing the chosen threshold of p-value 0.01 were
excluded, keeping 16 variables (pls see Table 1). The vari-
ables were then tested for high inter-correlation, which
could lead to a biased model towards the correlated
Fig. 1 Conceptual methodology applied in the present work to evaluate two approaches for CVD risk classification, a classical, statistically oriented risk
prediction tool and machine learning algorithms
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variables; however, no variables were excluded in this
final step (Pearson r correlation coefficients < 0.8).
Hence, at the end of the preprocessing phase the work-
ing dataset contained 16 baseline variables, the ones
shown in Table 1.
Statistical approach for CVD risk assessment: the
HellenicSCORE
The HellenicSCORE [31] is a calibration of the official
ESC SCORE and was calculated based on age, sex, smok-
ing status, systolic blood pressure and total cholesterol
levels of the participants’ baseline characteristics. Specific-
ally, based on (a) the risk factor prevalence that was ob-
tained from the baseline evaluation of the ATTICA study
in 2001–2002 [12, 27], (b) the annual death rates that were
obtained from the World Health Organization mortality
database for 2002 [32] accordance to the rules of the
International Classification of Diseases (ICD) [33], and (c)
the individuals’ characteristics, a recalibration method for
the Greek population was applied separately for men and
women, and the estimated 10-year risk for fatal CVD
events was calculated for each participant using Cox Pro-
portional Hazard models [12].
Machine learning methodologies for CVD risk assessment
Three different ML classifiers were chosen and hence,
three distinct models were created in order to distinct
whether an individual had a low or a high CVD risk. Ob-
viously, the list of tested algorithms is not exhaustive,
other methods such as Naive Bayes [34] or Support Vec-
tor Machines [35] could also be used, but preliminary
tests showed that the chosen classifiers give satisfying
results, with regards to missing data, outliers and com-
putational time. Another technique for implementing
ML, very well established and currently very popular, is
that of deep learning [36]. However, deep learning is typ-
ically applied when there is a very large amount of avail-
able data, which is not the case in our dataset since it
consists of around 2000 participants. For cases where
the available dataset is relatively small, traditional ma-
chine learning techniques prevail and thus, deep learn-
ing techniques were not considered.
ML techniques in general are applied in two stages: at
first, a (random) subset of the available data (called training
set) is used for the training of the model and next, the rest
of the data (called testing set) are used for the evaluation of
the model. The training set is used to induce a model, cap-
able of predicting the annotations of the instances in the
testing set. The choice of each subset’s elements is of major
importance and must be representative of the original data-
set, i.e. the sampling must be completely random and not
biased in any way. A common practice is to use a stratified
k-fold cross-validation (k-fold CV), where the data are par-
titioned into k segments of equal size (folds) which retain
the ratio between classes, and k independent iterations of
training/validation are performed.
As already mentioned, the three ML algorithms
chosen were k-NN, DT, and RF. The k-NN is one of
the simplest classifiers but yet quite efficient in general.
The data are clustered into similarity groups using k
“neighbors” for the classification of each individual.
The main principle is that instances within a dataset
will generally exist in close proximity to other instances
that have similar properties [37]. Once the instances are
Table 1 Description of the dataset containing the 16 baseline variables that were measured among n = 2020 ATTICA study
participants
Variable used in ML Male Female
Age in years, mean ± SD 46 ± 13 45 ± 14
Smoking status at baseline, %(yes) 44% 37%
Years of school mean ± SD 12.3 ± 3.6 12.0 ± 3.8
MedDietScore (range 0–55), mean ± SD 24 ± 5 27 ± 7
Basic metabolic rate as a proxy of energy expenditure 1783 ± 228 1384 ± 128
Body mass index in kg/m2, mean ± SD 27.3 ± 3.9 25.2 ± 4.7
Diastolic blood pressure levels in mmHg, mean ± SD 82 ± 11 76 ± 11
Systolic blood pressure levels in mmHg, mean ± SD 127 ± 17 118 ± 18
History of hypertension (including medication), % 39% 24%
Glucose levels (in mg/dl), mean ± SD 95 ± 25 90 ± 22
History of diabetes mellitus (including medication), % 8% 6%
Total cholesterol levels (in mg/dl), mean ± SD 197 ± 42 191 ± 41
Triglycerides (in mg/dl), mean ± SD 140 ± 102 98 ± 56
History of hypercholesterolemia (including medication), % 46% 38%
Interleukin-6 levels (ng/ml), mean ± SD 1.5 ± 0.5 1.4 ± 0.5
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binned into classes, then an unclassified instance can be
classified by observing the class of its nearest neighbors.
DT is a classifier, which uses a tree structure to locate the
connections among the data, making the decision process
quite transparent and informative. The tree structure clas-
sifies instances based on feature values: each tree node
covers a feature in an instance to be classified, and each
branch represents a value that the node can assume. Start-
ing from the root node, every instance is classified accord-
ing to their feature values. Using such decision algorithms,
a clinician may better visualize and classify an individual
into risk categories for developing a disease. In general
DTs make the classification process more “human read-
able”, e.g. the decision tree produced by the DT algorithm
shown in Fig. 2, does not need any expertise to be
followed and thus categorize an individual. RF is a
tree-based ensemble classifier, which provides additional
diversity in the created tree model; RF can also be seen as
an adaptively weighted potential nearest neighbor [38]
classifier. In general, ensemble methods create a stronger
learner by combining multiple weaker learners. RF models
are preferable to other tree-based classifiers, since they are
less prone to over-fitting [39]; however, unlike decision
trees, the rationale behind the produced model is not al-
ways easy to interpret. RF can cope with datasets with ex-
tremely large number of features since only the most
important features are considered by the algorithm.
Before starting the training of the ML models, some
additional preprocessing was necessary. The k-NN clus-
tering is using as metric the Euclidean distance between
the individuals; however, the quantitative variables of the
dataset had different ranges, so in order for each variable
to have the same impact on the distance, all numeric
variables were normalized into the range of [0,1].
Comparisons between ML approaches vs. HellenicSCORE
on 10-year CVD risk
Using the three ML techniques every individual was
classified into one of the two disjoint categories of “low”
(< 10%) and “high” (> 10%) 10-year CVD risk - following
also the rationale of the ESC classification. These classi-
fications were tested against the same classifications
resulting from the HellenicSCORE prediction tool, i.e.,
HellenicSCORE < 10% (n = 1912 individuals, 95% of the
sample) and > 10% (n = 108 individuals, 5% of the sam-
ple). Moreover, according to the observed 10-year CVD
incidence of ATTICA study, individuals were classified
as CVD-free (n = 1707, 84%) and CVD incident cases
(n = 317, 16%). The three ML techniques were trained
and evaluated using different sets of the preprocessed
data, in an attempt to achieve the best performance.
Specifically, the first set used included all the 16 avail-
able variables of the preprocessed data mentioned
above, that represent widely accepted CVD risk factors.
The second set contained only the 5 variables also used
for the calculation of the HellenicSCORE (i.e., age, sex,
smoking, total cholesterol, and systolic blood pressure
levels). The latter set was used in an attempt to explore
the performance of the ML models using only the data
available to the HellenicSCORE, i.e. comparing the
Fig. 2 An example of a Decision Tree (DT) derived using the 5-variable dataset (age, sex, systolic blood pressure levels (SBP), total cholesterol (TC),
and smoking). The thresholds for the quantitative variables (Age, TC, SBP) derived from the algorithm used to develop the DT
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performance of the two different approaches using the
same input data. While the first set was used in an at-
tempt to build a more complex model, exploiting add-
itional variables disregarded from the HellenicSCORE.
Additionally, since the different percentages of disease-
free individuals compared to cases inevitably leads to
biased models towards the healthy individuals, to over-
come this bias, two additional training datasets were
created, using bootstrapping techniques on both the 16
variables dataset and the 5 variables dataset.
Hence, to recap, five different comparisons were made:
1 ML_16_vs_HS: using as input the 16 variables, the
results were compared against the HellenicSCORE.
2 ML_16_vs_CVD: using as input the 16 variables, the
results were compared against the 10-year CVD in-
cidence of ATTICA study participants.
3 ML_16_Boot_vs_CVD: based on the 16 variables
and using bootstrap techniques a more balanced
training dataset was created and compared against
the 10-year CVD incidence.
4 ML_5_vs_CVD: using as input the 5 variables, the
results were compared against the 10-year CVD
incidence.
5 ML_5_Boot_vs_CVD: based on the 5 variables and
using bootstrap techniques a more balanced
training dataset was created and compared against
the 10-year CVD incidence.
Once the dataset was normalized, 10 different random
folds were created, each containing the 10% of the data-
set. Each fold was then divided into two disjoint sets;
one containing 90% of the fold data, used for the build-
ing of the k-NN model and the rest 10% for the evalu-
ation of the produced model. The chosen number of
neighbors to be considered in the construction of the
model was set to 3. No data normalization was needed
for the RF classifier. Regarding the folds, similarly to the
k-NN approach, the same 10 different random folds
were used. For each fold, an ensemble of trees was cre-
ated with each one having one vote and the model de-
cided on the classification of each individual using the
majority rule. The number of trees grown in every fold
in the construction of the model was set to 35. For the
case of the DT classifier, there was also no need for the
normalization of the variables. In order for the results to
be comparable with the two aforementioned methods,
the same 10 different random folds were used. Regard-
less of the chosen model, once it had been trained there
was a need to evaluate it against known data. For the
evaluation of each algorithm, the number of true positive
(TP) and false negative (FN) were counted for the indi-
viduals predicted as high CVD risk. Similarly, of the in-
dividuals predicted as low CVD risk, the number of true
negative (TN) and false negative positive (FN) were
counted. Based on these values, five metrics were calcu-
lated for each algorithm, to evaluate the diagnostic ac-
curacy, i.e. the amount of agreement between the results
from a model and those from the known data. Namely:
 Accuracy: the ratio of the correctly classified
individuals to the total number of individuals, i.e.
TPþTN
TPþTNþFPþFN .
 Sensitivity: the probability of predicting the
individual’s class as CVD risk hazardous when it
truly is CVD risk hazardous, i.e. TPTPþFN.
 Specificity: the probability of predicting the
individual’s class as non-CVD risk hazardous when
it truly is non-CVD risk hazardous, i.e. TNTNþFP.
 Positive Predictive Value (PPV): the probability the
individual is CVD risk hazardous when it is
predicted as such, i.e. TPTPþFP.
 Negative Predictive Value (NPV): the probability the
individual is non-CVD risk hazardous when it is pre-
dicted as such, i.e. TNTNþFN .
Neither of these metrics alone can absolutely characterize
the performance of a model, e.g. a high sensitivity alone
does not make a model a good model; it needs to also
recognize all individuals with low CVD risk, i.e. specificity.
However, in a daily practice, an individual will be more in-
terested in the PPV and NPV, i.e. the probability of being
high CVD risk after such a classification by the ML model.
Whereas the NPV is the probability of being low CVD risk
after such a classification by the ML model. All these met-
rics have different pros and cons, and they may be difficult
to unilaterally interpret [40]. Therefore, one sometimes pre-
fers a combination of them. For all the conducted types of
comparisons, regardless of the dataset and the ground truth
labels used for the evaluation, the same methodology was
applied to each ML technique. For each of the classifiers,
once all 10 models had been produced and evaluated, the
average performance across all models was calculated and
assigned as the total performance of the produced model.
All the implementations were carried out in the R pro-
gramming language [41] (version 3.3.3). For the k-NN clas-
sifier the class [24] R-package was used, for the DT
classifier the C50 [25] R-package, and for the RF the ran-
domForest [26] R-package. It is noted that the process of
creating the folds and using each different fold to train and
evaluate the classifier is computationally intensive, but the
procedure is completely independent for each fold and thus
it is possible to parallelize it by assigning each fold to a dif-
ferent computer core. Using in-house R scripts, the execu-
tion was parallelized into different computer cores,
achieving a speed-up almost equal to the number of com-
puter cores used for the calculations.
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Results
All the possible combinations of the five different compari-
sons mentioned in the Validation subsection and the three
different ML classifiers were performed, in order to evalu-
ate the performance of the ML. The performance metrics -
sensitivity, specificity, NPV, PPV and accuracy - of either
the HellenicSCORE or the ML classifiers on the observed
10-year CVD incidence, as well as the between ML classi-
fiers and HellenicSCORE classification, is presented in Ta-
bles 2, 3, 4, 5 and 6. In Table 2 the first comparison
(ML_16_vs_HS) is presented, where as it can be seen all
three ML methods had higher performance as compared to
HellenicSCORE classification, achieving accuracy rates of
96, 99, and 99% for the case of k-NN, RF, and DT classifier,
respectively. The same stands for the sensitivity rates, which
were 98% for the k-NN, 100% for the RF, and 99% for the
DTclassifier. However, DT outperformed all other methods
regarding specificity with a rate of 87% compared to 37 and
79% for the k-NN and RF classifiers. Regarding the PPV,
the lowest performance was 97% for the k-NN and the
highest 99% for the other two classifiers; however, the NPV
was 79% for k-NN, 89% for the DT and 98% for the RF. In
total, based on all five metrics the RF classifier achieved the
best performance, DT the second best, while k-NN had the
poorest performance. The specific comparison certified that
the ML techniques - especially RF and DT - had compar-
able efficiency one another and superiority to that of
HellenicSCORE.
For the rest of the comparisons, the evaluation was
measured against the observed 10-year CVD incidence. In
Table 3 the results from all the models built based on the
16 variables (ML_16_vs_CVD) are presented, while in
Table 4 the training dataset (ML_16_Boot_vs_CVD) as cre-
ated using bootstrapping. It is clear that the accuracy de-
creased slightly when bootstrapping was used; however,
the specificity increased more than double its value by the
usage of bootstrapping. This happened, since the ML
models were better trained to recognize unhealthy cases
in the test dataset. Regarding the ML models, once more
the RF one outperformed the one of DT, especially in the
bootstrap case. Indeed, the results of the ML methods
were completely comparable to the ones of Hellenic-
SCORE and performed better regarding specificity.
Similarly, in Table 5 the results are presented for the
models built using only the 5 variables also used for the
calculation of the HellenicSCORE (ML_5_vs_CVD) and
in Table 6 the same dataset (ML_5_Boot_vs_CVD) was
created using bootstrapping. The accuracy when no
bootstrapping was used was similar to that of the model
built with the 16 bootstrapping; however, the specificity
was less than half of it. When bootstrapping was used,
the specificity almost doubled, but still the accuracy and
the sensitivity decreased.
Therefore, in conclusion the better ML performance
was achieved when more variables were used for the
training of the models and the training was conducted
on bootstrapped dataset, i.e., when all 16 variables were
used and not only the 5 factors used for the calculation
of the HellenicSCORE. Since the performance metrics
for all classifiers were the mean values of respective met-
rics for the 10 folds, variances for all metrics per method
were calculated (data not shown). The variances were
small, meaning that the produced models of each fold
had similar efficiency and the data used in each fold
were homogenous with no significant outliers.
Discussion
Accurate risk prediction is a cornerstone in public health
care. Several risk prediction scores or tools have been pro-
posed that past years to identify the potential candidate
for developing a CVD or cancer event. However, their ac-
curacy in correcting classifying a candidate for developing
the disease, is doubtable. Thus, the use of risk tools at
population level, although of substantial clinical value, has
not been well appreciated. In this work we introduced ML
methodologies in predicting CVD events and compared
their classification with an already established and used
risk prediction tool. According to the presented results,
Table 2 Performance of the three ML algorithms using the 16-
variable dataset against the predicted 10-year CVD risk through
the HellenicSCORE
Algorithm Accuracy Specificity Sensitivity PPV NPV
k-NN 0.96 0.37 0.98 0.97 0.50
RF 0.99 0.79 1.00 0.99 0.98
DT 0.99 0.87 0.99 0.99 0.89
Table 3 Performance of the three ML algorithms using the 16-
variable dataset and of the HellenicSCORE, against the 10-year
CVD (fatal or non-fatal) incidence of ATTICA study participants
Algorithm Accuracy Specificity Sensitivity PPV NPV
k-NN 0.83 0.24 0.94 0.87 0.47
RF 0.84 0.20 0.96 0.87 0.46
DT 0.84 0.17 0.96 0.86 0.42
HellenicSCORE 0.85 0.20 0.97 0.87 0.58
Table 4 Performance of the three ML algorithms using the 16-
variable dataset with bootstrapping and of the HellenicSCORE,
against the 10-year CVD (fatal or non-fatal) incidence of ATTICA
study participants
Algorithm Accuracy Specificity Sensitivity PPV NPV
k-NN 0.65 0.56 0.67 0.89 0.24
RF 0.83 0.46 0.89 0.90 0.45
DT 0.80 0.53 0.85 0.91 0.40
HellenicSCORE 0.85 0.20 0.97 0.87 0.58
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the application of ML approaches in CVD risk predic-
tion may further assist in correctly identifying individ-
uals at high risk and in applying more effective
population-based strategies. Regarding the specificity
and the NPV, the results were more satisfying when
bootstrapping was applied for the creation of the train-
ing dataset. Indeed, bootstrapping techniques lead to a
less biased model toward the healthy individuals, since
the training sets are generating from the original data-
set with replacement, and thus making them balanced
by including more well-adjusted number of healthy and
unhealthy individuals. However, regarding the k-NN
classifier, especially for the case that a larger set of vari-
ables was used combined with bootstrapping, the re-
sults for specificity and sensitivity, as well as the NPV,
were not so promising. Some reasons for that might be
the inherent outlier sensitivity of the specific algorithm,
combined with the large dimensionality of the used
data; k-NN is known to suffer sometimes from the
Bias-Variance tradeoff [42], i.e., it can become over-fit-
ted to the training data and perform poorly on the test-
ing data.
At this point it could be argued that the ML ap-
proaches are more complicated, compared to the clas-
sical risk prediction tools. However, nowadays, where
information technology has become a “daily” use prac-
tice in clinical setting, the development of ML-based
tools where a clinician can easily impute with basic and
simple individuals’ characteristics and correctly calculate
their future risk for CVD or any other disease, would be
of considerable importance for the public health. More-
over, although ML may be more complicated than the
common risk prediction tools, a main advantage of the
ML approach is their inherent ability to evolve large sets
of variables, based on the accumulated data, i.e., the
more data that become available, the better model is
built without any a-priori defined methodological re-
strictions. In addition, and in contrary to the classical
risk prediction tools, simply repeating the training phase
of the classifier, using the accumulated data, does the
building of a new model, more accurate, which is a
cornerstone in public health care setting. Additionally,
the unbiased view of the available data by the ML algo-
rithms, can lead to the discovery of previously unseen
relationships among data, which were very often present,
but ML allowed them to visualize, whereas the classical
approaches may not due to models restrictions. How-
ever, one may claim that the use of more variables to
build the ML model than the risk prediction tool (i.e., 16
vs. 5 variables) lead to a a-priori defined superiority of
the ML model due the higher information used. The use
of a relatively small set of variables in risk prediction
tools is common in practice because of two main rea-
sons: the need to be the risk classification as simple as
possible in terms of general public health use, but also
the pre-requirement of the models not to be parsimoni-
ous and to reduce the level of undesirable colinearity.
Nevertheless, ML models performed similar compared
to the risk prediction tools even when the same set of
variables used. Therefore, although the results of com-
parison between ML and classical approaches were com-
parable, in the near future the abundance of available
data and the discovery of unseen so far relations, will
render ML a very powerful tool for the life scientists in
the CVD risk prediction.
In ML applications due to the larger number of vari-
ables typically taken under consideration compared to
classical approaches, the created ML model is often con-
sidered as a “black box”, since the model’s details are too
complex to be presented to the end user. The models
created by the k-NN and RF classifiers fall into the latter
category. Although they have been evaluated and new
individuals can be classified, the rationale behind the de-
cision to eventually categorize one individual into one
category or the other is not transparent. This happens in
the attempt to hide the complex mathematics models
implemented, based on the training dataset. This neces-
sary issue is common knowledge in the area of ML,
however, especially for health issues the patient wants to
be able to know the reasons she or he was categorized
into one class over the other. On the contrary, the deci-
sion tree created by the DT classifier is much more
straightforward to understand, without special know-
ledge. This simplicity in the model representation often
comes with the cost of the model being more “naive”; in-
deed, the DT classifier has a lower performance com-
pared to the RF one. As a limitation, it must be noted
that the current study like other similar studies [20, 43,
Table 5 Performance of the three ML algorithms using the 5
variables dataset and of the HellenicSCORE, against the 10-year
CVD (fatal or non-fatal) incidence of ATTICA study participants
Algorithm Accuracy Specificity Sensitivity PPV NPV
k-NN 0.82 0.21 0.93 0.86 0.35
RF 0.84 0.22 0.95 0.87 0.45
DT 0.84 0.14 0.97 0.86 0.49
HellenicSCORE 0.85 0.20 0.97 0.87 0.58
Table 6 Performance of the three ML algorithms using the 5
variables dataset with bootstrapping and of the HellenicSCORE,
against the 10-year CVD incidence of ATTICA study participants
Algorithm Accuracy Specificity Sensitivity PPV NPV
k-NN 0.66 0.62 0.67 0.91 0.26
RF 0.79 0.47 0.85 0.90 0.37
DT 0.78 0.48 0.84 0.90 0.36
HellenicSCORE 0.85 0.20 0.97 0.87 0.58
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44] was based on a cohort of small to medium size.
Ideally, the same methodology would be replicated using
data of a much larger cohort, in order to further support
the findings. Additionally, the highly disproportional
percentages of individuals having high CVD risk com-
pared to those with low risk inevitably leads to biased
models towards the individuals with low risk, i.e., the
models built are better at correctly identifying low CVD
risk individuals compared to high risk ones. This can be
seen on all three models, where the sensitivity was much
higher than the specificity; in other words, the model
produces relatively more FP than FN, since it can
recognize easier a low risk individual over a high risk
one. The latter was handled by using bootstrapped data
for the training of the ML models and thus artificially
balancing the abundance of healthy individuals com-
pared to CVD ones.
Conclusions
This study explored the potential of applying ML ap-
proaches on population data, alternatively to the estab-
lished risk prediction tools. The results showed that ML
performs comparable well with the established risk tools
in identifying a potential candidate for CVD develop-
ment. In particular, three machine-learning classifiers
were compared against an estimation tool for CVD risk
prediction, as well as against actual CVD incidence, giv-
ing very high accuracy, sensitivity, and PPV for the clas-
sification. A main advantage of the ML approaches is
their inherent ability to evolve large sets of variables,
based on the accumulated data, i.e., the more data that
become available, a better model is built without any
a-priori defined methodological restrictions. In addition,
and in contrary to the established approaches, simply re-
peating the training phase of the classifier, using the ac-
cumulated data, does the building of a new model, more
accurate and automatic. Additionally, the unbiased view
of the available data by the ML algorithms, can lead to
the discovery of previously unseen relationships among
data, which were always present, but ML allowed them
to visualize, whereas the classical approach may not –
mainly due to the constraint of colinearity. Therefore, al-
though the results of comparison between ML and clas-
sical approaches were comparable, in the near future the
abundance of available data and the discovery of unseen
so far relations, will render ML a very powerful tool for
the life scientists in the CVD risk prediction. To con-
clude, based on the presented results, the ML approach
can prove a valuable and helpful methodology in the
field of CVD risk prediction, and not only, making
prognostication algorithms easier to understand and use
in clinical practice. Indeed, in spite of the claims that ML
classification techniques can result in adequate and effect-
ive decision making very few have actually penetrated the
clinical practice [19]. As a future step, in the effort of es-
tablishing ML in the field of CVD prediction, larger data-
sets will be sought, which will allow to build more
accurate models. Ideally, such datasets will contain indi-
viduals from various nationalities, making the built models
international. Indeed, such datasets can be produced from
the available databases of the currently ongoing ATHLOS
(Ageing Trajectories of Health: Longitudinal Opportun-
ities and Synergies) project. Once the various datasets are
homogenized, numerous different ML models will be
tested; given the large number of available individuals
Deep Learning techniques could also be tested. Therefore,
all the above will allow us to identify and understand rela-
tionships between CVD and various lifestyle characteris-
tics yet undiscovered by the available tools.
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